Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis

Pramod Kuchulakanti; Seung-Woon Rha; Lowell F. Satler; William O. Suddath; Augusto D. Pichard; Kenneth M. Kent; Rajbabu Pakala; Daniel A. Canos; Ellen E. Pinnow; Ron Waksman

doi:10.1016/j.amjcard.2004.02.038

Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis

Pramod Kuchulakanti, Seung-Woon Rha, Lowell F. Satler, William O. Suddath, Augusto D. Pichard, Kenneth M. Kent, Rajbabu Pakala, Daniel A. Canos, Ellen E. Pinnow, Ron Waksman

Research output: Contribution to journal › Article

2 Citations (Scopus)

Abstract

Side branch occlusion is 1 mechanism for the increase of creatine phosphokinase-MB after percutaneous coronary intervention and is associated with long-term adverse events. We studied 248 patients who underwent brachytherapy for in-stent restenosis with and without side branches, compared levels of creatine phosphokinase-MB with procedural, in-hospital, and long-term clinical outcomes, and found that patients with side branches have increased levels of creatine phosphokinase-MB after percutaneous coronary intervention and higher rates of restenosis, target vessel, and target lesion revascularization at 6-month follow-up.

Original language	English
Pages (from-to)	1394-1397
Number of pages	4
Journal	American Journal of Cardiology
Volume	93
Issue number	11
DOIs	https://doi.org/10.1016/j.amjcard.2004.02.038
Publication status	Published - 2004 Jun 1
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

Kuchulakanti, P., Rha, S-W., Satler, L. F., Suddath, W. O., Pichard, A. D., Kent, K. M., Pakala, R., Canos, D. A., Pinnow, E. E., & Waksman, R. (2004). Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis. American Journal of Cardiology, 93(11), 1394-1397. https://doi.org/10.1016/j.amjcard.2004.02.038

Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis. / Kuchulakanti, Pramod; Rha, Seung-Woon; Satler, Lowell F.; Suddath, William O.; Pichard, Augusto D.; Kent, Kenneth M.; Pakala, Rajbabu; Canos, Daniel A.; Pinnow, Ellen E.; Waksman, Ron.

In: American Journal of Cardiology, Vol. 93, No. 11, 01.06.2004, p. 1394-1397.

Research output: Contribution to journal › Article

Kuchulakanti, P, Rha, S-W, Satler, LF, Suddath, WO, Pichard, AD, Kent, KM, Pakala, R, Canos, DA, Pinnow, EE & Waksman, R 2004, 'Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis', American Journal of Cardiology, vol. 93, no. 11, pp. 1394-1397. https://doi.org/10.1016/j.amjcard.2004.02.038

Kuchulakanti, Pramod ; Rha, Seung-Woon ; Satler, Lowell F. ; Suddath, William O. ; Pichard, Augusto D. ; Kent, Kenneth M. ; Pakala, Rajbabu ; Canos, Daniel A. ; Pinnow, Ellen E. ; Waksman, Ron. / Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis. In: American Journal of Cardiology. 2004 ; Vol. 93, No. 11. pp. 1394-1397.

@article{0194e60b069b46b88dd30cd090fdfb8d,

title = "Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis",

abstract = "Side branch occlusion is 1 mechanism for the increase of creatine phosphokinase-MB after percutaneous coronary intervention and is associated with long-term adverse events. We studied 248 patients who underwent brachytherapy for in-stent restenosis with and without side branches, compared levels of creatine phosphokinase-MB with procedural, in-hospital, and long-term clinical outcomes, and found that patients with side branches have increased levels of creatine phosphokinase-MB after percutaneous coronary intervention and higher rates of restenosis, target vessel, and target lesion revascularization at 6-month follow-up.",

author = "Pramod Kuchulakanti and Seung-Woon Rha and Satler, {Lowell F.} and Suddath, {William O.} and Pichard, {Augusto D.} and Kent, {Kenneth M.} and Rajbabu Pakala and Canos, {Daniel A.} and Pinnow, {Ellen E.} and Ron Waksman",

year = "2004",

month = jun

day = "1",

doi = "10.1016/j.amjcard.2004.02.038",

language = "English",

volume = "93",

pages = "1394--1397",

journal = "American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Impact of major side branch on periprocedural enzyme elevation and long-term outcome in patients undergoing percutaneous coronary intervention and brachytherapy for in-stent restenosis

AU - Kuchulakanti, Pramod

AU - Rha, Seung-Woon

AU - Satler, Lowell F.

AU - Suddath, William O.

AU - Pichard, Augusto D.

AU - Kent, Kenneth M.

AU - Pakala, Rajbabu

AU - Canos, Daniel A.

AU - Pinnow, Ellen E.

AU - Waksman, Ron

PY - 2004/6/1

Y1 - 2004/6/1

N2 - Side branch occlusion is 1 mechanism for the increase of creatine phosphokinase-MB after percutaneous coronary intervention and is associated with long-term adverse events. We studied 248 patients who underwent brachytherapy for in-stent restenosis with and without side branches, compared levels of creatine phosphokinase-MB with procedural, in-hospital, and long-term clinical outcomes, and found that patients with side branches have increased levels of creatine phosphokinase-MB after percutaneous coronary intervention and higher rates of restenosis, target vessel, and target lesion revascularization at 6-month follow-up.

AB - Side branch occlusion is 1 mechanism for the increase of creatine phosphokinase-MB after percutaneous coronary intervention and is associated with long-term adverse events. We studied 248 patients who underwent brachytherapy for in-stent restenosis with and without side branches, compared levels of creatine phosphokinase-MB with procedural, in-hospital, and long-term clinical outcomes, and found that patients with side branches have increased levels of creatine phosphokinase-MB after percutaneous coronary intervention and higher rates of restenosis, target vessel, and target lesion revascularization at 6-month follow-up.

UR - http://www.scopus.com/inward/record.url?scp=2542444448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542444448&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2004.02.038

DO - 10.1016/j.amjcard.2004.02.038

M3 - Article

C2 - 15165922

AN - SCOPUS:2542444448

VL - 93

SP - 1394

EP - 1397

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 11

ER -

Access to Document

10.1016/j.amjcard.2004.02.038